Federation des caisses Desjardins du Quebec’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-80	Closed	-$4.1K	–	2516
2020 Q4	$4.1K	Buy	+80	New	+$3.81K	﹤0.01%	2120
2018 Q4	–	Sell	-450	Closed	-$17.7K	–	2139
2018 Q3	$17.7K	Hold	450	–	–	﹤0.01%	1587
2018 Q2	$16.8K	Hold	450	–	–	﹤0.01%	1613
2018 Q1	$15.4K	Hold	450	–	–	﹤0.01%	1614
2017 Q4	$14.8K	Hold	450	–	–	﹤0.01%	1635
2017 Q3	$14K	Hold	450	–	–	﹤0.01%	1600
2017 Q2	$12.5K	Hold	450	–	–	﹤0.01%	1676
2017 Q1	$11.6K	Buy	+450	New	+$11.2K	﹤0.01%	1401

Other funds holding SBIO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return

CCP

Cardan Capital Partners Denver, Colorado $893M AUM 22.82% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's SBIO Position: Q1 2021 in Review

Federation des caisses Desjardins du Quebec sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q1 2021, closing a stake of 80 shares — an estimated $4.1K sold.

Federation des caisses Desjardins du Quebec first reported a position in SBIO in Q1 2017 and held it in 8 quarters. The position peaked at $17.7K in Q3 2018. 70 funds tracked by Wall St. Rank hold SBIO as of Q1 2021.

Federation des caisses Desjardins du Quebec reported no remaining ALPS Medical Breakthroughs ETF position as of Q1 2021 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 80 ALPS Medical Breakthroughs ETF shares in Q1 2021, an estimated $4.1K.
Federation des caisses Desjardins du Quebec first reported a position in ALPS Medical Breakthroughs ETF in Q1 2017 and held it in 8 quarters.
Federation des caisses Desjardins du Quebec's ALPS Medical Breakthroughs ETF position peaked at $17.7K in Q3 2018.
70 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2021.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2021, filed 30 Aug 2024.